Stocks
MiMedx Group, Inc.MDXG
NASDAQHealthcareBiotechnology$4.38+0.00%
Specializing in regenerative biologics, the company develops and distributes placental tissue allografts for wound care and surgical applications. It has gained investor attention for its innovative approach to addressing chronic and acute wounds, as well as its potential in the growing biologics market.
Market Cap: $650.7M52W Range: $4.34 – $8.13
Congressional Interest in MiMedx Group, Inc. (MDXG)
1 member of Congress has disclosed 1 trade in MiMedx Group, Inc. (MDXG), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading MDXG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-05-30 | Tom Malinowski | sell | $15K – $50K |